PARKINSON DISEASE, LATE-ONSET
|
disease |
|
Disease or Syndrome
|
247
|
76
|
0.100 |
None |
0.909 |
11 |
|
2017 |
2020 |
Motor symptoms
|
phenotype |
|
Sign or Symptom
|
100
|
15
|
0.100 |
None |
0.900 |
10 |
|
2017 |
2019 |
Blood spots
|
disease |
|
Disease or Syndrome
|
117
|
|
0.060 |
None |
1.000 |
6 |
|
2004 |
2019 |
Systolic Pressure
|
phenotype |
|
Clinical Attribute
|
843
|
1931
|
0.100 |
None |
1.000 |
4 |
2
|
2017 |
2019 |
[D]Sleep disturbances (& [hypersomnia] or [insomnia])
|
phenotype |
|
Sign or Symptom
|
69
|
23
|
0.020 |
None |
1.000 |
2 |
|
2019 |
2019 |
Nodule
|
phenotype |
|
Acquired Abnormality
|
278
|
19
|
0.010 |
None |
1.000 |
1 |
|
2017 |
2017 |
Inattention
|
phenotype |
|
Mental or Behavioral Dysfunction
|
66
|
22
|
0.010 |
None |
1.000 |
1 |
|
2017 |
2017 |
Deformity of spine
|
disease |
|
Anatomical Abnormality
|
58
|
2
|
0.010 |
None |
1.000 |
1 |
|
2017 |
2017 |
Psychotic symptom
|
phenotype |
|
Sign or Symptom
|
86
|
21
|
0.010 |
None |
1.000 |
1 |
|
2017 |
2017 |
Pisa syndrome
|
disease |
|
Disease or Syndrome
|
4
|
|
0.010 |
None |
1.000 |
1 |
|
2018 |
2018 |
Coagulation factor measurement
|
phenotype |
|
Laboratory Procedure
|
14
|
26
|
0.100 |
None |
1.000 |
1 |
2
|
2013 |
2013 |
Positive myoclonus
|
phenotype |
|
Sign or Symptom
|
3
|
|
0.010 |
None |
1.000 |
1 |
|
2019 |
2019 |
von Willebrand's factor (lab test)
|
phenotype |
|
Laboratory Procedure
|
55
|
427
|
0.100 |
None |
1.000 |
1 |
11
|
2013 |
2013 |
Factor VII measurement
|
phenotype |
|
Laboratory Procedure
|
16
|
36
|
0.100 |
None |
1.000 |
1 |
5
|
2019 |
2019 |
End stage Parkinson's disease
|
disease |
|
Disease or Syndrome
|
3
|
|
0.010 |
None |
1.000 |
1 |
|
2019 |
2019 |
Impulsive Behavior
|
phenotype |
Behavior and Behavior Mechanisms
|
Mental or Behavioral Dysfunction
|
276
|
69
|
0.040 |
None |
1.000 |
4 |
|
2017 |
2019 |
Mental Depression
|
disease |
Behavior and Behavior Mechanisms
|
Mental or Behavioral Dysfunction
|
1478
|
271
|
0.030 |
None |
1.000 |
3 |
|
2018 |
2019 |
Depressed mood
|
phenotype |
Behavior and Behavior Mechanisms
|
Mental or Behavioral Dysfunction
|
1461
|
269
|
0.030 |
None |
1.000 |
3 |
|
2018 |
2019 |
Abnormal behavior
|
phenotype |
Behavior and Behavior Mechanisms
|
Mental or Behavioral Dysfunction
|
910
|
121
|
0.010 |
None |
1.000 |
1 |
|
2017 |
2017 |
Cardiovascular Diseases
|
group |
Cardiovascular Diseases
|
Disease or Syndrome
|
1756
|
711
|
0.110 |
None |
1.000 |
2 |
1
|
2016 |
2019 |
Arteriosclerosis
|
disease |
Cardiovascular Diseases
|
Disease or Syndrome
|
2006
|
267
|
0.010 |
None |
1.000 |
1 |
|
2016 |
2016 |
Atherosclerosis
|
disease |
Cardiovascular Diseases
|
Disease or Syndrome
|
2044
|
281
|
0.010 |
None |
1.000 |
1 |
|
2016 |
2016 |
Coronary Artery Disease
|
disease |
Cardiovascular Diseases
|
Disease or Syndrome
|
1708
|
1577
|
0.100 |
None |
1.000 |
1 |
2
|
2018 |
2018 |
Drug usage
|
phenotype |
Chemically-Induced Disorders; Mental Disorders
|
Mental or Behavioral Dysfunction
|
170
|
21
|
0.030 |
None |
0.667 |
3 |
|
2018 |
2018 |
Drug habituation
|
phenotype |
Chemically-Induced Disorders; Mental Disorders
|
Mental or Behavioral Dysfunction
|
196
|
19
|
0.010 |
None |
1.000 |
1 |
|
2019 |
2019 |